DWP450 for Treating Moderate to Severe Glabellar Lines
Clinical trial NCT06354127 · COMPLETED
Trial details
- NCT number
- NCT06354127
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-12
- Primary completion
- 2020-11-24
- Enrollment
- 473
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.